Advertisement

Index by author

July 01, 1993; Volume 266,Issue 1

  1. Tonello, C

    1. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
      E Nisoli, C Tonello, R Imhof, R Scherschlicht, M da Prada and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 97-105;

  2. Torphy, T J

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

  3. Tsai, C E

    1. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
      E A Johnson, C E Tsai, Y H Shahan and A J Azzaro
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 133-141;

  4. Uchida, M K

    1. Ca(++)-independent relaxation mediated by beta adrenoceptor in Ca(++)-independent contraction of uterine smooth muscle.
      T Ishine, Y Miyauchi and M K Uchida
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 367-373;

  5. Undem, B J

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

  6. Underwood, D C

    1. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
      D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;

  7. Wada, T

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  8. Wang, S Z

    1. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
      S Z Wang and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 237-243;

  9. Watanabe, A M

    1. Comparison of adenosine and muscarinic receptor-mediated effects on protein phosphatase inhibitor-1 activity in the heart.
      R C Gupta, J Neumann and A M Watanabe
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 16-22;

  10. Weinshilboum, R M

    1. Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.
      T A Glauser, A N Nelson, D E Zembower, J J Lipsky and R M Weinshilboum
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 23-32;
« Previous (Pages : 19 20 21 22 23 24 ... 24) Next »
Back to top

In this issue

Advertisement